InMed Pharmaceuticals Inc. (INM) Insider Trading Activity

NASDAQ$1.7382+0.06 (3.57%)
Market Cap
$9.23M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
117 of 849
Rank in Industry
3 of 48

Largest Insider Buys in Sector

$350M
$217M
$172M
$109M
$107M
$104M

INM Insider Trading Activity

INM Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,360,451
32
100
Sells
$0
0
0

Related Transactions

ADAR1 Capital Management, LLC10 percent owner
17
$926,902
0
$0
$926,902
Vivo Opportunity, LLC10 percent owner
15
$433,549
0
$0
$433,549

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candidate, the company is also developing INM-088, which is undergoing preclinical studies for glaucoma treatment, and INM-405, intended for pain relief. Its …

Insider Activity of InMed Pharmaceuticals Inc.

Over the last 12 months, insiders at InMed Pharmaceuticals Inc. have bought $1.36M and sold $0 worth of InMed Pharmaceuticals Inc. stock.

On average, over the past 5 years, insiders at InMed Pharmaceuticals Inc. have bought $481,221 and sold $42 worth of stock each year.

Highest buying activity among insiders over the last 12 months: ADAR1 Capital Management, LLC (10 percent owner) — $926,902. Vivo Opportunity, LLC (10 percent owner) — $433,549.

The last purchase of 4 shares for transaction amount of $5 was made by ADAR1 Capital Management, LLC (10 percent owner) on 2026‑10‑23.

List of Insider Buy and Sell Transactions, InMed Pharmaceuticals Inc.

2026-10-23PurchaseADAR1 Capital Management, LLC10 percent owner
4
<0.0001%
$1.32
$5
+11.11%
2026-10-19PurchaseADAR1 Capital Management, LLC10 percent owner
1,086
0.0191%
$1.32
$1,434
+16.45%
2026-10-16PurchaseADAR1 Capital Management, LLC10 percent owner
1
<0.0001%
$1.32
$1
+20.45%
2026-10-15PurchaseADAR1 Capital Management, LLC10 percent owner
984
0.0178%
$1.32
$1,301
+19.55%
2026-10-14PurchaseADAR1 Capital Management, LLC10 percent owner
8,021
0.1482%
$1.33
$10,668
+15.65%
2026-10-13PurchaseADAR1 Capital Management, LLC10 percent owner
564
0.0103%
$1.33
$750
+8.27%
2026-10-08PurchaseADAR1 Capital Management, LLC10 percent owner
2,256
0.041%
$1.33
$2,997
+2.46%
2026-10-07PurchaseADAR1 Capital Management, LLC10 percent owner
3,046
0.0554%
$1.33
$4,051
+2.26%
2026-10-06PurchaseADAR1 Capital Management, LLC10 percent owner
5,601
0.1018%
$1.33
$7,436
+2.26%
2026-10-05PurchaseADAR1 Capital Management, LLC10 percent owner
18,182
0.4158%
$1.33
$24,182
+2.26%
2026-10-02PurchaseADAR1 Capital Management, LLC10 percent owner
8,307
0.1899%
$1.33
$11,048
+2.26%
2026-10-01PurchaseADAR1 Capital Management, LLC10 percent owner
16,431
0.3701%
$1.33
$21,850
+0.74%
2026-09-16PurchaseADAR1 Capital Management, LLC10 percent owner
8,340
0.464%
$1.29
$10,750
+6.25%
2026-09-15PurchaseADAR1 Capital Management, LLC10 percent owner
54,256
3.0408%
$1.30
$70,446
+6.25%
2026-09-14PurchaseADAR1 Capital Management, LLC10 percent owner
28,505
0.6487%
$1.29
$36,880
+4.62%
2026-07-16PurchaseVivo Opportunity, LLC10 percent owner
21
0.0011%
$1.55
$33
-11.95%
2026-07-15PurchaseADAR1 Capital Management, LLC10 percent owner
1,000
0.054%
$1.55
$1,555
-11.95%
2026-07-15PurchaseVivo Opportunity, LLC10 percent owner
15,150
0.816%
$1.55
$23,483
-11.95%
2026-07-14PurchaseVivo Opportunity, LLC10 percent owner
5,375
0.2951%
$1.55
$8,331
-10.26%
2026-07-02PurchaseVivo Opportunity, LLC10 percent owner
1,607
0.0866%
$1.55
$2,491
-8.33%
Total: 44
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
ADAR1 Capital Management, LLC10 percent owner
956584
17.4123%
$1.61M170
Vivo Opportunity, LLC10 percent owner
743057
13.5255%
$1.25M150
Johnson Shane AaronSVP, GM of BayMedica LLC
304595
5.5444%
$511,719.6030
<0.0001%
ADAMS ERIC APresident & CEO
43959
0.8002%
$73,851.1250
<0.0001%
HULL ANDREWdirector
38258
0.6964%
$64,273.4410
COLWILL BRUCECFO
11515
0.2096%
$19,345.2020
<0.0001%
*Gray background shows insiders who have made transactions during last year

INM Institutional Investors: Active Positions

Increased Positions3+21.43%25,108+8.27%
Decreased Positions5-35.71%101,648-33.48%
New Positions3New25,108New
Sold Out Positions4Sold Out83,283Sold Out
Total Postitions12-14.29%227,050-25.21%

INM Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Sabby Management, Llc$246.007.33%219,998+219,998New2025-09-30
Drw Securities, Llc$40.001.2%35,865+35,865New2025-09-30
Virtu Financial Llc$23.000.68%20,369+20,369New2025-09-30
Renaissance Technologies Llc$19.000.56%16,800+16,800New2025-09-30
Thompson Davis & Co., Inc.$11.000.34%10,249+10,249New2025-09-30
Sbi Securities Co., Ltd.$00.01%30000%2025-09-30
Banque Cantonale Vaudoise$00%600%2025-09-30
Federation Des Caisses Desjardins Du Quebec$00%2+<1New2025-09-30
Allsquare Wealth Management Llc$00%100%2025-06-30
Bessemer Group Inc$00%0<1Sold Out2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.